Navigation Links
Direct-to-consumer genetic testing -- 2-day symposium
Date:8/26/2009

Companies are increasingly offering genetic tests directly to consumers to assess their risk for illnesses such as breast cancer or diabetes. These tests have raised concerns over whether people will receive adequate counseling -- given that the tests are not administered by health care providers -- and whether consumers' genetic information will be kept private, among other issues.

On Aug. 31 and Sept. 1 the National Research Council and Institute of Medicine will hold a symposium to explore the health, policy, and ethical implications of direct-to-consumer genetic testing.

SYMPOSIUM DETAILS: 8 a.m. to 5 p.m. on Aug. 31 and from 9 a.m. to 2:30 p.m. on Sept. 1 in Room 100 of the National Academies' Keck Center, 500 Fifth St., N.W., Washington, D.C. A preliminary agenda is available at http://sites.nationalacademies.org/PGA/stl/PGA_050739.

AUDIO WEBCAST: Morning sessions on Aug. 31 -- covering the history and likely evolution of direct-to-consumer genetic testing, as well as the regulatory framework -- will be available via live audio webcast at http://national-academies.org.


'/>"/>

Contact: Sara Frueh
news@nas.edu
202-334-2138
National Academy of Sciences
Source:Eurekalert

Page: 1

Related biology news :

1. Direct-to-consumer advertising for genetic tests concerns physicians and may mislead patients
2. Scientists link genetic glitches to common childhood cancer
3. Researchers find genetic link between physical pain and social rejection
4. Scientists take early steps toward mapping epigenetic variability
5. USC researchers identify regulatory genetic sequences that may predict risk for prostate cancer
6. Carnegie Mellon develops innovative method to detect genetic causes of complex diseases
7. New study suggests possible genetic links between environmental toxins and multiple myeloma
8. Discovery of genetic mutation in Leigh syndrome
9. Joint research into an enzyme that causes genetic diseases
10. First genetically-engineered malaria vaccine to enter human trials
11. Comprehensive look at rare leukemia finds relatively few genetic changes launch disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2016)... , June 22, 2016   ... management and verification solutions, has partnered with ... software solutions for Visitor Management, Self-Service Kiosks ... provides products that add functional enhancements to ... provides corporations and venues with an automated ...
(Date:6/16/2016)... FRANCISCO , June 16, 2016 ... size is expected to reach USD 1.83 ... by Grand View Research, Inc. Technological proliferation and ... banking applications are expected to drive the market ... ) , The development of advanced ...
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. ... a business relationship that includes integrating Syngrafii,s patented ... branch project. This collaboration will result in greater ... the credit union, while maintaining existing document workflow ... http://photos.prnewswire.com/prnh/20160606/375871LOGO ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... Raleigh, NC (PRWEB) , ... June 27, 2016 ... ... have just published their findings on what they believe could be a new ... summary of the new research. Click here to read it now. ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... the funding of a Sponsored Research Agreement with ... tumor cells (CTCs) from cancer patients.  The funding ... CTC levels correlate with clinical outcomes in cancer ... data will then be employed to support the ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of ... the Cary 5000 and the 6000i models are higher end machines that use the ... of the spectrophotometer’s light beam from the bottom of the cuvette holder. , ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
Breaking Biology Technology: